Trapidil attenuates diabetic cardiomyopathy via GPX3/Nrf2-mediated inhibition of myocardial pyroptosis

Trapidil attenuates diabetic cardiomyopathy via GPX3/Nrf2-mediated inhibition of myocardial pyroptosis

BackgroundCurrently, there is a paucity of clinically effective medications for the treatment of diabetic cardiomyopathy (DCM), while the strategy of drug repurposing offers a promising avenue for advancing therapeutic development.MethodsThe investigation explored the ameliorative effects and uncove...

Full description

Saved in:
Bibliographic Details
Main Authors: Zihao Wang, Yingzi Sun, Juanjuan Wang, Qiuyue Xu, Liuxing Wang, Qi Zhang, Juan Song, Yuchun Wang, Zhanpeng Qi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Pharmacology
Subjects:
diabetic cardiomyopathy
pyroptosis
trapidil
GPX3
Nrf2
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1566622/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1566622/full

Similar Items